false000007233100000723312024-12-112024-12-11

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 11, 2024
NORDSON CORPORATION
(Exact Name of Registrant as Specified in its Charter)
Ohio000-0797734-0590250
(State or Other
Jurisdiction of Incorporation)
(Commission File Number)
(I.R.S. Employer
Identification Number)
28601 Clemens Road
Westlake, Ohio 44145
(Address of Principal Executive
Offices, including Zip Code)
Registrant’s Telephone Number, including Area Code: 440-892-1580
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol(s)Name of Each Exchange
On Which Registered
Common Shares, without par valueNDSNNasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933(§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 2.02.    Results of Operations and Financial Condition.
On December 11, 2024, Nordson Corporation issued a press release relating to its results of operations for the fourth quarter and full fiscal year 2024.  A copy is attached as Exhibit 99.1.
Item 7.01.    Regulation FD Disclosure.
Nordson Corporation will provide additional commentary on fourth quarter and full year fiscal 2024 results and outlook during a webcast on Thursday, December 12, 2024 at 8:30 a.m. eastern time, which can be accessed at https://investors.nordson.com. For persons unable to listen to the live broadcast, a replay will be available after the event.
As provided in General Instruction B.2 of Form 8-K, the information contained in Items 2.02 and 7.01 of this Form 8-K shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall any such information be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01    Financial Statements and Exhibits.(d) Exhibits.
(d) Exhibits.
Press release of Nordson Corporation dated December 11, 2024.
104
Cover Page Interactive Data File (embedded within the inline XBRL document).


SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
NORDSON CORPORATION
Date:
December 11, 2024
By: /s/ Stephen Shamrock
Stephen Shamrock
Chief Accounting Officer



Nordson Corporation Reports Fourth Quarter and Fiscal Year 2024 Results
Fourth Quarter:
•Sales were $744 million, a 4% increase over prior year
•Earnings per diluted share were $2.12
•Adjusted earnings per diluted share were $2.78
•Atrion Medical acquisition integration progressing well

Full Year:
•Record sales of $2.7 billion, reflecting 2% growth over last year’s record sales
•Earnings per diluted share were $8.11
•EBITDA was a record $849 million, up 4% over prior year and 32% of sales
•Adjusted earnings per diluted share were $9.73

Fiscal 2025 Guidance:
•Fiscal 2025 forecasted sales range between $2,750 to $2,870 million and adjusted earnings in the range of $9.70 to $10.50

WESTLAKE, Ohio--(BUSINESS WIRE)--December 11, 2024--Nordson Corporation (Nasdaq: NDSN) today reported results for the fiscal fourth quarter ended October 31, 2024. Sales were $744 million, a 4% increase compared to the prior year’s fourth quarter sales of $719 million. The increase in fourth quarter 2024 sales included the favorable 6% impact of acquisitions and favorable currency translation of 1%, offset by an organic sales decrease of 3%.
Net income was $122 million, or earnings per diluted share of $2.12, compared to prior year’s fourth quarter net income of $128 million, or earnings per diluted share of $2.22. Adjusted net income was $160 million, an increase from prior year adjusted net income of $156 million. Fourth quarter 2024 adjusted earnings per diluted share were $2.78 compared to prior year adjusted earnings per diluted share of $2.71.
EBITDA in the fourth quarter was $241 million, or 32% of sales, an increase of 4% compared to prior year EBITDA of $227 million, also at 32% of sales.
Commenting on the Company’s fiscal 2024 fourth quarter results, Nordson President and Chief Executive Officer Sundaram Nagarajan said, “I appreciate our team’s focus and commitment to our customers, which delivered results above our fourth quarter guidance expectations. Our Advanced Technology Solutions segment delivered year-over-year fourth quarter sales growth, as electronics demand continued to steadily improve at fiscal year-end. During the down electronics cycle, our ATS team holistically implemented the NBS Next growth framework, making them responsive to the needs of our customers while also delivering a strong incremental operating performance. Our industrial product lines performed well against record comparisons from prior year. I’m also pleased with the early integration of our Atrion Medical acquisition, which contributed positively to the quarter.”
Fourth Quarter Segment Results
Industrial Precision Solutions sales of $392 million decreased 3% compared to the prior year fourth quarter, driven by a 5% organic sales decrease, a favorable acquisition impact of 1%, and a favorable currency impact of 1%. The organic sales decrease, following record organic sales in prior year fourth quarter, was driven by our industrial coatings, polymer processing and precision agriculture product lines, partially offset by double-digit growth in nonwovens product lines. Operating profit was $126 million in the quarter, or 32% of sales, a decrease of 4% compared to the prior year operating profit. The decrease in operating profit was driven by lower sales. EBITDA in the quarter was $143 million, or 37% of sales, a 3% decrease from the prior year fourth quarter EBITDA of $148 million, which also was 37% of sales.

Medical and Fluid Solutions sales of $200 million increased 19% compared to the prior year fourth quarter, driven primarily by the acquisition of Atrion, which offset an organic sales decrease of 3% and a favorable currency impact of 1%. The organic sales decrease was driven by softness in medical interventional solutions product lines, partially offset by modest growth in our medical fluid components and fluid solutions product lines. Operating profit totaled $44 million in the quarter, or 22% of sales,
1

a decrease of 8% compared to the prior year operating profit. EBITDA in the quarter was $72 million, or 36% of sales, an increase versus the prior year fourth quarter EBITDA of $62 million, or 37% of sales.

Advanced Technology Solutions sales of $152 million increased 5% compared to the prior year fourth quarter, driven by an organic sales increase of 4% and a favorable currency impact of 1%. The organic sales increase was driven by double-digit growth in select test and inspection product lines and modest growth in our electronics processing product lines. Operating profit totaled $33 million in the quarter, or 22% of sales, an increase of 6% compared to the prior year operating profit due to higher sales and improved profit margins. EBITDA in the quarter was $41 million, or 27% of sales, an increase from the prior year fourth quarter EBITDA of $35 million, or 24% of sales.

Fiscal 2024 Full Year Results
Sales for the fiscal year ended October 31, 2024, were a record $2.7 billion, an increase of 2% compared to the prior year. This sales growth was driven by a favorable acquisition impact of 5%, partially offset by a 3% decrease in organic volume.
Net income was $467 million, or earnings per diluted share of $8.11, compared to prior year’s net income of $487 million, or earnings per diluted share of $8.46. Adjusted net income was $561 million, a decrease from prior year adjusted net income of $567 million. Adjusted earnings per diluted share were $9.73 compared to prior year adjusted earnings per diluted share of $9.85.
EBITDA was $849 million, or 32% of sales, compared to prior year EBITDA of $819 million, or 31% of sales. Free cash flow for the full-year was $492 million, which was a conversion rate of 105% of net income.
Reflecting on fiscal 2024, Mr. Nagarajan continued, “In 2021, we launched our Ascend strategy with the milestone of achieving $3 billion in annual sales and greater than 30% EBITDA margins by 2025. The strategy is delivering results and has ample runway to accelerate. Our diversified portfolio, built on our leadership in niche end markets with differentiated products, is delivering balanced results in the ever-changing macro environment. Our acquisition strategy is generating growth, and I am pleased with the integration and deployment of the NBS Next growth framework. We also continued to generate strong free cash flow in the year, allowing us to consistently reinvest in the business while returning cash to our shareholders.”
Outlook
Following four consecutive years of record-setting performance, we enter fiscal 2025 with approximately $580 million in backlog.
Based on the combination of order entry, backlog, current exchange rates and anticipated end market expectations, we anticipate delivering sales in the range of $2,750 to $2,870 million in fiscal 2025. Full year fiscal 2025 adjusted earnings are forecasted in the range of $9.70 to $10.50 per diluted share.
First quarter fiscal 2025 sales are forecasted in the range of $615 to $655 million with adjusted earnings in the range of $1.95 to $2.15 per diluted share.
Commenting on fiscal 2025 guidance, Nagarajan said, “Considering the evolving global macro-environment, we are entering 2025 with a conservative viewpoint. The fiscal first quarter is seasonally Nordson’s weakest quarter due to the holiday and calendar year-end slowdowns and cautious customer spending. While we remain confident about the long-term growth drivers of our end markets, we are being prudent about our expectations for end market recovery timing, particularly for our electronics and agricultural product lines. Even in uncertain times, our team delivers operational excellence and strong cash flow due to our close-to-the-customer business model, diversified niche end markets, differentiated products and the NBS Next growth framework.”
Nordson management will provide additional commentary on these results and outlook during its previously announced webcast on Thursday, December 12, 2024 at 8:30 a.m. eastern time, which can be accessed at https://investors.nordson.com. Information about Nordson’s investor relations and shareholder services is available from Lara Mahoney, vice president, investor relations and corporate communications at (440) 204-9985 or lara.mahoney@nordson.com.
Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by terminology such as “may,” “will,” “should,” “could,” “expects,” “anticipates,” “believes,” “projects,” “forecasts,” “outlook,” “guidance,” “continue,” “target,” or the negative of these terms or comparable terminology. These statements reflect management’s current expectations and involve a number of risks and uncertainties. These risks and uncertainties include, but are not limited to, U.S. and international economic conditions; financial and market conditions; currency exchange rates and devaluations; possible acquisitions, including the Company’s ability to successfully integrate acquisitions; the Company’s ability to successfully divest or dispose of businesses
2

that are deemed not to fit with its strategic plan; the effects of changes in U.S. trade policy and trade agreements; the effects of changes in tax law; and the possible effects of events beyond our control, such as political unrest, including the conflict between Russia and Ukraine, acts of terror, natural disasters and pandemics, including the recent coronavirus (COVID-19) pandemic and the other factors discussed in Item 1A (Risk Factors) in the Company’s most recently filed Annual Report on Form 10-K and in its Forms 10-Q filed with the Securities and Exchange Commission, which should be reviewed carefully. The Company undertakes no obligation to update or revise any forward-looking statement in this press release.

Nordson Corporation is an innovative precision technology company that leverages a scalable growth framework through an entrepreneurial, division-led organization to deliver top tier growth with leading margins and returns. The Company’s direct sales model and applications expertise serves global customers through a wide variety of critical applications. Its diverse end market exposure includes consumer non-durable, medical, electronics and industrial end markets. Founded in 1954 and headquartered in Westlake, Ohio, the Company has operations and support offices in over 35 countries. Visit Nordson on the web at www.nordson.com, linkedin/Nordson, or www.facebook.com/nordson.
3

NORDSON CORPORATION
CONSOLIDATED STATEMENT OF INCOME (Unaudited)
(Dollars in thousands except for per-share amounts)
Three Months EndedTwelve Months Ended
October 31, 2024October 31, 2023October 31, 2024October 31, 2023
Sales$744,482 $719,313 $2,689,921 $2,628,632 
Cost of sales341,658 335,220 1,203,792 1,203,227 
Gross profit402,824 384,093 1,486,129 1,425,405 
Gross margin %54.1 %53.4 %55.2 %54.2 %
Selling & administrative expenses223,932 199,054 812,128 752,644 
Operating profit178,892 185,039 674,001 672,761 
Interest expense - net(27,282)(25,921)(84,011)(56,825)
Other income (expense) - net(3,538)1,462 (4,509)(597)
Income before income taxes148,072 160,580 585,481 615,339 
Income taxes25,904 32,802 118,197 127,846 
Net Income$122,168 $127,778 $467,284 $487,493 
Weighted-average common shares outstanding:
Basic57,188 57,020 57,176 57,090 
Diluted57,603 57,552 57,616 57,631 
Earnings per share:
Basic earnings$2.14 $2.24 $8.17 $8.54 
Diluted earnings$2.12 $2.22 $8.11 $8.46 
4

NORDSON CORPORATION
CONSOLIDATED BALANCE SHEET (Unaudited)
(Dollars in thousands)
October 31, 2024October 31, 2023
Cash and cash equivalents$115,952 $115,679 
Receivables - net594,663 590,886 
Inventories - net476,935 454,775 
Other current assets87,482 67,970 
Total current assets1,275,032  1,229,310 
Property, plant & equipment - net544,607 392,846 
Goodwill3,280,819 2,784,201 
Other assets900,508 845,413 
$6,000,966 $5,251,770 
Notes payable and debt due within one year$103,928 $115,662 
Accounts payable and accrued liabilities424,549 466,427 
Total current liabilities528,477 582,089 
Long-term debt2,101,197 1,621,394 
Other liabilities439,100 450,227 
Total shareholders' equity2,932,192 2,598,060 
$6,000,966 $5,251,770 

5

NORDSON CORPORATION
CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)
(Dollars in thousands)
Twelve Months Ended
October 31, 2024October 31, 2023
Cash flows from operating activities:
Net Income$467,284 $487,493 
Depreciation and amortization136,175 111,898 
Other non-cash items5,883 16,105 
Changes in operating assets and liabilities and other    (53,149)25,786 
Net cash provided by operating activities    556,193 641,282 
Cash flows from investing activities:
Additions to property, plant and equipment(64,410)(34,583)
Acquisitions of businesses, net of cash acquired    (789,996)(1,422,780)
Other - net10,008 20,484 
Net cash used in investing activities(844,398)(1,436,879)
Cash flows from financing activities:
Issuance (repayment) of long-term debt464,353 976,043 
Repayment of finance lease obligations(6,148)(6,840)
Dividends paid(161,438)(150,356)
Issuance of common shares31,067 21,373 
Purchase of treasury shares(33,339)(89,708)
Net cash provided by financing activities294,495 750,512 
Effect of exchange rate change on cash(6,017)(2,693)
Net change in cash and cash equivalents273 (47,778)
Cash and cash equivalents:
Beginning of period115,679 163,457 
End of period$115,952 $115,679 
6

NORDSON CORPORATION
SALES BY GEOGRAPHIC SEGMENT (Unaudited)
(Dollars in thousands)
Three Months EndedSales Variance
October 31, 2024October 31, 2023OrganicAcquisitionsCurrencyTotal
SALES BY SEGMENT
Industrial precision solutions$392,150 $405,436 (5.5)%1.2 %1.0 %(3.3)%
Medical and fluid solutions200,223 168,632 (3.2)%21.4 %0.5 %18.7 %
Advanced technology solutions152,109 145,245 3.9 %— %0.8 %4.7 %
Total sales$744,482 $719,313 (3.0)%5.7 %0.8 %3.5 %
SALES BY GEOGRAPHIC REGION
Americas323,170 315,635 (6.0)%8.9 %(0.5)%2.4 %
Europe185,350 184,297 (6.6)%4.6 %2.6 %0.6 %
Asia Pacific235,962 219,381 4.2 %2.0 %1.4 %7.6 %
Total sales$744,482 $719,313 (3.0)%5.7 %0.8 %3.5 %
Twelve Months EndedSales Variance
October 31, 2024October 31, 2023OrganicAcquisitionsCurrencyTotal
SALES BY SEGMENT
Industrial precision solutions$1,484,249 $1,391,046 0.1 %6.6 %— %6.7 %
Medical and fluid solutions695,452 660,316 (0.2)%5.4 %0.1 %5.3 %
Advanced technology solutions510,220 577,270 (11.4)%— %(0.2)%(11.6)%
Total sales$2,689,921 $2,628,632 (2.5)%4.8 %— %2.3 %
SALES BY GEOGRAPHIC REGION
Americas1,178,626 1,149,760 (1.9)%4.3 %0.1 %2.5 %
Europe726,100 682,676 (5.1)%10.2 %1.3 %6.4 %
Asia Pacific785,195 796,196 (1.0)%1.0 %(1.4)%(1.4)%
Total sales$2,689,921 $2,628,632 (2.5)%4.8 %— %2.3 %
7

NORDSON CORPORATION
RECONCILIATION OF NON-GAAP MEASURES - NET INCOME TO EBITDA (Unaudited)
(Dollars in thousands)

Three Months EndedTwelve Months Ended
October 31, 2024October 31, 2023October 31, 2024October 31, 2023
Net income122,168 127,778 467,284 487,493 
Income taxes25,904 32,802 118,197 127,846 
Interest expense - net27,282 25,921 84,011 56,825 
Other expense - net3,538 (1,462)4,509 597 
Depreciation and amortization36,528 31,261 136,175 111,898 
Inventory step-up amortization (1)
4,759 4,556 7,703 8,862 
Severance and other (1)
12,717 — 17,332 5,487 
Acquisition-related costs (1)
8,200 6,244 13,957 19,966 
EBITDA (non-GAAP) (2)
241,096 227,100 849,168 818,974 
(1) Represents severance as well as fees and non-cash inventory charges associated with acquisitions.
(2) EBITDA is a non-GAAP measure used by management to evaluate the Company's ongoing operations. EBITDA is defined as operating profit plus certain adjustments, such as severance, fees and non-cash inventory charges associated with acquisitions, plus depreciation and amortization.
8

NORDSON CORPORATION
RECONCILIATION OF NON-GAAP MEASURES - EBITDA (Unaudited)
(Dollars in thousands)
Three Months EndedTwelve Months Ended
October 31, 2024October 31, 2023October 31, 2024October 31, 2023
SALES BY SEGMENT
Industrial precision solutions$392,150 $405,436 $1,484,249 $1,391,046 
Medical and fluid solutions200,223 168,632 695,452 660,316 
Advanced technology solutions152,109 145,245 510,220 577,270 
Total sales$744,482 $719,313 $2,689,921 $2,628,632 
OPERATING PROFIT
Industrial precision solutions$126,254 $131,450 $470,559 $460,889 
Medical and fluid solutions44,264 48,041 187,731 189,367 
Advanced technology solutions33,464 31,526 94,231 101,662 
Corporate(25,090)(25,978)(78,520)(79,157)
Total operating profit$178,892 $185,039 $674,001 $672,761 
OPERATING PROFIT ADJUSTMENTS (1)
Industrial precision solutions$2,899 $4,658 $8,976 $4,658 
Medical and fluid solutions10,761 — 10,761 1,479 
Advanced technology solutions3,816 — 5,895 14,304 
Corporate8,200 6,142 13,360 13,874 
Total adjustments$25,676 $10,800 $38,992 $34,315 
DEPRECIATION & AMORTIZATION
Industrial precision solutions$14,035 $12,062 $56,856 $33,228 
Medical and fluid solutions17,239 13,547 58,061 54,988 
Advanced technology solutions3,340 3,529 13,433 15,185 
Corporate1,914 2,123 7,825 8,497 
Total depreciation & amortization$36,528 $31,261 $136,175 $111,898 
EBITDA (NON-GAAP) (2)
Industrial precision solutions$143,188 37 %$148,170 37 %$536,391 36 %$498,775 36 %
Medical and fluid solutions72,264 36 %61,588 37 %256,553 37 %245,834 37 %
Advanced technology solutions40,620 27 %35,055 24 %113,559 22 %131,151 23 %
Corporate(14,976)(17,713)(57,335)(56,786)
Total EBITDA$241,096 32 %$227,100 32 %$849,168 32 %$818,974 31 %
(1) Represents severance as well as fees and non-cash inventory charges associated with acquisitions.
(2) EBITDA is a non-GAAP measure used by management to evaluate the Company's ongoing operations. EBITDA is defined as operating profit plus certain adjustments, such as severance, fees and non-cash inventory charges associated with acquisitions, plus depreciation and amortization.
9

NORDSON CORPORATION
RECONCILIATION OF NON-GAAP MEASURES - ADJUSTED NET INCOME AND EARNINGS PER SHARE (Unaudited)
(Dollars in thousands)
Three Months EndedTwelve Months Ended
October 31, 2024October 31, 2023October 31, 2024October 31, 2023
GAAP AS REPORTED
Operating profit$178,892 $185,039 $674,001 $672,761 
Other / interest expense - net(30,820)(24,459)(88,520)(57,422)
Net income122,168 127,778 467,284 487,493 
Diluted earnings per share$2.12 $2.22 $8.11 $8.46 
Shares outstanding - diluted57,603 57,552 57,616 57,631 
OPERATING PROFIT ADJUSTMENTS
Inventory step-up amortization$4,759 $4,556 $7,703 $8,862 
Severance and other 12,717 — 17,332 5,487 
Acquisition costs8,200 6,244 13,957 19,966 
ACQUISITION AMORTIZATION OF INTANGIBLES$19,560 $17,880 $76,972 $59,719 
INTEREST908 6,817 908 6,817 
Total adjustments$46,144 $35,497 $116,872 $100,851 
Adjustments net of tax$38,071 $28,247 $93,278 $79,898 
EPS effect of adjustments and other discrete tax items$0.66 $0.49 $1.62 $1.39 
NON-GAAP MEASURES-ADJUSTED NET INCOME AND ADJUSTED EARNINGS PER SHARE
Adjusted net income (1)
$160,239 $156,025 $560,562 $567,391 
Adjusted earnings per share (2)
$2.78 $2.71 $9.73 $9.85 
(1) Adjusted net income is a non-GAAP measure defined as net income plus tax effected adjustments and other discrete tax items.
(2) Adjusted earnings per share is a non-GAAP measure defined as GAAP EPS adjusted for tax effected adjustments and other discrete tax items.

10

NORDSON CORPORATION
RECONCILIATION OF NON-GAAP MEASURES - OPERATING CASH FLOW TO FREE CASH FLOW (Unaudited)
(Dollars in thousands)
Year to Date
October 31, 2024July 31, 2024April 30, 2024January 31, 2024
Net cash provided by operating activities$556,193 $459,812 $294,964 $172,356 
Additions to property, plant and equipment(64,410)(43,786)(21,907)(7,530)
Free Cash Flow - Year to Date (1)
491,783 416,026 273,057 164,826 
Free Cash Flow - Quarter to Date (2)
75,757 142,969 108,231 164,826 
Net Income - Year to Date$467,284 
Free Cash Flow Conversion (3)
105 %
 
Year to Date
October 31, 2023July 31, 2023April 30, 2023January 31, 2023
Net cash provided by operating activities$641,282 $478,072 $287,905 $123,337 
Additions to property, plant and equipment(34,583)(24,244)(15,349)(9,302)
Free Cash Flow (1)
606,699 453,828 272,556 114,035 
Free Cash Flow - Quarter to Date (2)
152,871 181,272 158,521 114,035 
(1) Free Cash Flow - Year to Date is a non-GAAP measure used by management to evaluate the Company's ongoing operations and is defined as Net cash provided by operating activities minus Additions to property, plant and equipment.
(2) Free Cash Flow - Quarter to Date is a non-GAAP measure used by management to evaluate the Company's ongoing operations and is equal to Free Cash Flow - Year to Date less prior period Free Cash Flow - Year to Date.
(3) Free Cash Flow Conversion - Year to Date is a non-GAAP measure used by management to evaluate the Company's ongoing operations and is defined as Free Cash Flow - Year to Date divided by Net Income - Year to Date.


Management uses certain non-GAAP measures, such as adjusted net income, adjusted EPS and EBITDA, internally to make strategic decisions, forecast future results, and evaluate the Company's current performance. Given management's use of these non-GAAP measures, the Company believes these measures are important to investors in understanding the Company's current and future operating results as seen through the eyes of management. In addition, management believes these non-GAAP measures are useful to investors in enabling them to better assess changes in the Company's core business across different time periods. Because non-GAAP financial measures are not standardized, it may not be possible to compare these financial measures to other companies' non-GAAP financial measures, even if they have similar names. Amounts may not add due to rounding.

Contact
Lara Mahoney
Vice President,
Investor Relations & Corporate Communications
440.204.9985
Lara.Mahoney@nordson.com
11
v3.24.3
Cover
Dec. 11, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date Dec. 11, 2024
Entity Registrant Name NORDSON CORPORATION
Amendment Flag false
Entity Central Index Key 0000072331
Entity Incorporation, State or Country Code OH
Entity File Number 000-07977
Entity Tax Identification Number 34-0590250
Entity Address, Address Line One 28601 Clemens Road
Entity Address, City or Town Westlake
Entity Address, State or Province OH
Entity Address, Postal Zip Code 44145
City Area Code 440
Local Phone Number 892-1580
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Shares, without par value
Trading Symbol NDSN
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Grafico Azioni Nordson (NASDAQ:NDSN)
Storico
Da Nov 2024 a Dic 2024 Clicca qui per i Grafici di Nordson
Grafico Azioni Nordson (NASDAQ:NDSN)
Storico
Da Dic 2023 a Dic 2024 Clicca qui per i Grafici di Nordson